Methylene Blue — What It Is, How It Works & Why Purity Matters
Methylene Blue (MB) is one of the most fascinating compounds in modern integrative health — and one of the most misunderstood. It has a history stretching back to 1876, was the first pharmaceutical drug prescribed in the United States, and sits on the World Health Organisation’s List of Essential Medicines. Yet most people have never heard of it.
That is changing rapidly. A growing body of research — and a growing community of researchers, physicians, and biohackers — is shining a light on what low-dose Methylene Blue may offer for mitochondrial health, cognitive function, antiviral defence, and more.
This guide covers what MB is, how it works, what the research says, who the key experts are, and — critically — why the quality of what you take matters enormously.
A Brief History
Methylene Blue was first synthesised in 1876 by German chemist Heinrich Caro. It was initially used as a textile dye, but its biological properties were quickly recognised. By the late 19th century it was being used as a biological stain to visualise cells and bacteria under the microscope — a technique still used in laboratories today.
In medicine, MB became one of the earliest synthetic drugs. It was used to treat malaria, methemoglobinemia (a condition where haemoglobin cannot carry oxygen effectively), and carbon monoxide poisoning — where it helps displace carbon monoxide from red blood cells and restore normal oxygen transport. It was also one of the first compounds used in psychiatry, administered to patients with psychosis in the early 20th century.
Today it remains on the WHO Essential Medicines List and is used in hospitals worldwide. But the most exciting frontier is what low-dose MB may offer for everyday health optimisation.
What Makes Methylene Blue Unique
MB is a redox-active compound — meaning it can cycle between oxidised and reduced states, donating and accepting electrons. This makes it an electron carrier, and it is this property that underpins most of its biological activity.
It is also notable for its excellent oral bioavailability. Unlike many compounds that are poorly absorbed when taken orally — NAD being a well-known example — MB is well absorbed through the gut and crosses the blood-brain barrier readily. This makes it highly accessible as a supplement.
Mitochondrial Function & Energy Production
The most researched mechanism of Methylene Blue is its interaction with the mitochondrial electron transport chain — the system your cells use to produce ATP (energy).
MB binds to cytochrome c oxidase (Complex IV), the final enzyme in the chain, improving the efficiency of oxygen utilisation and ATP production. It can also act as an alternative electron carrier, effectively bypassing blockages in the chain and supporting energy production even when the system is under stress or dysfunction.
This has profound implications. Mitochondrial dysfunction is increasingly recognised as a root factor in a wide range of chronic health challenges — from fatigue and brain fog to metabolic disease and neurodegeneration. Supporting mitochondrial efficiency is one of the most fundamental things you can do for long-term health.
Cognitive Enhancement & Neuroprotection
The cognitive effects of low-dose Methylene Blue have been studied extensively by Dr. Francisco Gonzalez-Lima, a neuroscientist at the University of Texas at Austin and the leading academic researcher in this field.
“Methylene blue is the oldest synthetic drug used in medicine and has a remarkable history of diverse therapeutic applications.” — Gonzalez-Lima & Barksdale, 2014
His research suggests that at low doses, MB may support:
- Memory consolidation — particularly the encoding of new memories
- Cerebral blood flow — supporting oxygen and nutrient delivery to the brain
- Mitochondrial respiration in neurons — keeping brain cells energised and resilient
- BDNF elevation — brain-derived neurotrophic factor supports the survival of existing neurons and the growth of new ones, vital for learning and memory
MB also acts as a mild monoamine oxidase inhibitor (MAOI), allowing neurotransmitters like serotonin to remain active longer in the synapse. This contributes to its potential mood-supporting and cognitive-clarity effects.
A commonly discussed low-dose protocol in the research and biohacking community is around 10mg taken in the morning, on an empty stomach or with food.
Antiviral & Antimicrobial Properties
MB has a well-documented history as an antimicrobial agent. Its antiviral properties operate through several mechanisms:
- Oxidative stress induction — when activated by light, MB generates reactive oxygen species (ROS) that interfere with viral replication
- Inhibition of viral entry — MB disrupts the cellular pathways viruses use to penetrate host cells
- Immune support via mitochondria — healthy mitochondria are central to innate immune function; by supporting mitochondrial efficiency, MB may enhance the body’s capacity to respond to viral threats
Anecdotal reports and early investigations have explored MB’s relevance to viral respiratory conditions, including COVID-19, with some accounts describing rapid symptom relief and patients reportedly testing negative within days of use. This remains an emerging and evolving area of research.
Red Light Synergy
Both Methylene Blue and red/near-infrared light independently support mitochondrial function via cytochrome c oxidase. Some researchers suggest their combined use may have an additive or synergistic effect on cellular energy production. This is an emerging area of research attracting significant interest in the photobiomodulation community.
What the Experts Say
Dr. Francisco Gonzalez-Lima — Neuroscientist, UT Austin
The foremost academic researcher on MB and the brain. His published work forms the scientific foundation for much of the current interest in low-dose MB for cognitive health and neuroprotection.
Dr. Craig Koniver — Physician & Performance Medicine Specialist
Dr. Koniver is a practitioner actively using Methylene Blue clinically and is one of the most prominent medical voices discussing its real-world applications. He has spoken extensively about MB’s role in cognitive enhancement, mitochondrial support, and its potential in addressing COVID-19 symptoms. His clinical perspective bridges the gap between emerging research and practical application.
Dr. Peter Attia — Physician & Longevity Expert
Host of The Peter Attia Drive podcast and a leading voice in longevity medicine. Dr. Attia has discussed MB in the context of mitochondrial health and healthspan optimisation — his framework of addressing root causes of metabolic and cognitive decline aligns closely with MB’s mechanisms.
Dr. Rhonda Patrick — Biomedical Scientist
Known for her work on micronutrients, mitochondria, and longevity via her FoundMyFitness platform. Dr. Patrick has explored MB as part of her broader research into compounds that support cellular energy and brain health.
Dr. Matthew Johnson — Professor of Psychiatry, Johns Hopkins
A leading researcher in psychopharmacology. His expertise in how compounds affect brain chemistry and neuroplasticity provides relevant context for understanding MB’s neurochemical mechanisms, particularly its MAOI activity.
Expert references are provided for informational and educational context only.
Why Purity Is Non-Negotiable
Not all Methylene Blue is equal — and this is not a minor point. MB is a compound that readily binds to heavy metals and other contaminants. Low-grade or industrial preparations can contain significant levels of arsenic, lead, and other toxins. Taking contaminated MB defeats the purpose entirely and introduces serious risk.
The minimum standard worth considering is USP pharmaceutical grade with independent third-party heavy metal testing. At The Gumpii Apothecary, we have our purity independently tested by Centricor Analytical Labs. Test results are available on request.
If you are sourcing MB elsewhere, always ask for the grade and the test results. If a supplier cannot provide them, look elsewhere.
Understanding Micro-Dosing
The research on Methylene Blue consistently distinguishes between low (sub-therapeutic) doses and higher therapeutic doses. The areas of interest described in this article relate specifically to very low doses — typically in the range of 0.5 to 4mg/kg. At higher doses, MB behaves very differently and the risk profile changes significantly.
The liquid format is important for this reason — it allows for precise measurement of very small amounts. Practitioner guidance is strongly recommended.
What to Expect
Methylene Blue will turn urine blue or green — this is completely normal and expected at any dose. Some people also notice temporary blue discolouration of the tongue or lips immediately after taking it. Both effects are harmless.
An interesting observation in the research community: if you take MB and notice no colour change in urine, some interpret this as a sign that the mitochondria are absorbing and utilising it fully — suggesting significant mitochondrial demand. This is an area of ongoing discussion rather than established science, but worth being aware of.
Important Safety Information
Methylene Blue is not suitable for everyone. Key contraindications and cautions:
- Do not use with antidepressants, SSRIs, SNRIs, MAOIs, or other serotonergic medications — serious interactions are possible due to MB’s MAOI activity
- Not suitable for those with G6PD deficiency
- Not suitable during pregnancy or breastfeeding
- Not suitable for children
- Consult your healthcare practitioner if you have any medical condition, take any medication, or are scheduled for surgery
Explore Further
Content provided for informational purposes only. Not medical advice. Not intended to diagnose, treat, or cure any condition. Consult your healthcare practitioner.